Methionine-Dependence Phenotype in the De Novo Pathway in BRCA1 and BRCA2 Mutation Carriers With and Without Breast Cancer

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-08-0140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review With Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

miRNA Expression Profiling of Hereditary Breast Tumors From BRCA1- And BRCA2-germline Mutation Carriers in Brazil

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

JAMA - Journal of the American Medical Association
Medicine
2004English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy